WNT6 is a novel oncogenic prognostic biomarker in human glioblastoma.

MLA

Gonçalves, Céline S., et al. “WNT6 Is a Novel Oncogenic Prognostic Biomarker in Human Glioblastoma.” Theranostics, vol. 8, no. 17, Sept. 2018, pp. 4805–23. EBSCOhost, https://doi.org/10.7150/thno.25025.

APA

Gonçalves, C. S., Vieira de Castro, J., Pojo, M., Martins, E. P., Queirós, S., Chautard, E., Taipa, R., Pires, M. M., Pinto, A. A., Pardal, F., Custódia, C., Faria, C. C., Clara, C., Reis, R. M., Sousa, N., & Costa, B. M. (2018). WNT6 is a novel oncogenic prognostic biomarker in human glioblastoma. Theranostics, 8(17), 4805–4823. https://doi.org/10.7150/thno.25025

Chicago

Gonçalves, Céline S, Joana Vieira de Castro, Marta Pojo, Eduarda P Martins, Sandro Queirós, Emmanuel Chautard, Ricardo Taipa, et al. 2018. “WNT6 Is a Novel Oncogenic Prognostic Biomarker in Human Glioblastoma.” Theranostics 8 (17): 4805–23. doi:10.7150/thno.25025.